selective factor XIa serine protease inhibitor

oral in higher species, eff. in thrombosis model

from PK optimization of prior series

J. Med. Chem., May 26, 2020

Bristol Myers Squibb, Princeton, NJ

Structure of compound 6f

“Compound 6f” is a potent macrocyclic factor XIa inhibitor (<1 nM) that is highly selective against other serine proteases and has excellent oral PK (high bioavailability, low clearance). The…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: